Thromb Haemost 1991; 65(05): 631-634
DOI: 10.1055/s-0038-1648202
Scientific and Standardization Committee Communications
Schattauer GmbH Stuttgart

Recommendations for the Evaluation and Treatment of Neonatal Autoimmune and Alloimmune Thrombocytopenia

J Bussel
The Department of Pediatrics, Cornell Medical College, New York, N.Y., U.S.A., the Institut National de Transfusion Sanguine, Paris, France, and Blood Center of Southeast Wisconsin, U.S.A.
,
C Kaplan
The Department of Pediatrics, Cornell Medical College, New York, N.Y., U.S.A., the Institut National de Transfusion Sanguine, Paris, France, and Blood Center of Southeast Wisconsin, U.S.A.
,
J McFarland
The Department of Pediatrics, Cornell Medical College, New York, N.Y., U.S.A., the Institut National de Transfusion Sanguine, Paris, France, and Blood Center of Southeast Wisconsin, U.S.A.
,
Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Preview

Summary

The following recommendations of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH for the management of neonatal immune thrombocytopenia were prepared by the working party on neonatal immune thrombocytopenia. Evaluation, diagnosis, and treatment of the mother and neonate with alloimmune and autoimmune thrombocytopenia are discussed and current recommendations provided. This document is likely to require frequent future revision(s).